Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence.

acute coronary syndrome coronary angiography coronary artery disease systemic inflammatory index systemic inflammatory response index

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Aug 2022
Historique:
received: 30 07 2022
revised: 19 08 2022
accepted: 19 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Atherosclerosis, the underlying cause of coronary artery disease (CAD), has a significant inflammatory component. White blood cell count is an affordable and accessible way to assess the systemic immune response, as it comprises many subgroups with distinct and complex functions. Considering their multidirectional effect on atherosclerosis, new biomarkers integrating various leukocyte subgroups, the Systemic Inflammatory Index (SII) and the Systemic Inflammatory Response Index (SIRI), were recently devised to describe the balance between inflammation and immune reaction. This research aimed to evaluate the relationship of the intensity of inflammation measured by these biomarkers with the severity of CAD assessed with coronary angiography and with the diagnosis of acute coronary syndrome (ACS) or stable CAD in 699 patients. SIRI, but not SII, was associated with the diagnosis, having the highest values for patients with ACS (STEMI), significantly higher than in patients with stable CAD (p < 0.01). The highest SII and SIRI values were observed in patients with three-vessel CAD. SII and SIRI require further in-depth and well-designed research to evaluate their potential in a clinical setting.

Identifiants

pubmed: 36076952
pii: ijms23179553
doi: 10.3390/ijms23179553
pmc: PMC9455822
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University of Warsaw
ID : 2F5/PM2/16

Références

J Clin Med. 2022 Jan 28;11(3):
pubmed: 35160157
Circulation. 1996 May 15;93(10):1784-7
pubmed: 8635255
Clin Chim Acta. 2016 Jan 30;453:21-7
pubmed: 26633855
Medeni Med J. 2021 Dec 19;36(4):318-324
pubmed: 34939398
Cardiol Res Pract. 2012;2012:181394
pubmed: 22577589
Biomark Med. 2017 Nov;11(11):979-990
pubmed: 28891324
Circ Res. 2019 Feb;124(3):437-450
pubmed: 30702995
Circulation. 2004 Aug 3;110(5):579-87
pubmed: 15277326
Scand Cardiovasc J. 2021 Apr;55(2):91-96
pubmed: 33263444
Angiology. 2021 Oct;72(9):889-895
pubmed: 33827291
Med Sci Monit. 2019 Dec 18;25:9690-9701
pubmed: 31849367
Diagnostics (Basel). 2022 Mar 04;12(3):
pubmed: 35328187
J Inflamm Res. 2021 Jan 18;14:131-140
pubmed: 33500649
Open Heart. 2016 Sep 05;3(2):e000477
pubmed: 27621833
Circ Res. 2014 Jun 6;114(12):1867-79
pubmed: 24902971
Coron Artery Dis. 2021 Dec 1;32(8):715-720
pubmed: 33826540
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Int J Mol Sci. 2017 Sep 22;18(10):
pubmed: 28937652
Front Med (Lausanne). 2022 Mar 16;9:841601
pubmed: 35372392
J Am Coll Cardiol. 2019 Sep 24;74(12):1594-1607
pubmed: 31537270
Front Cardiovasc Med. 2022 May 03;9:811790
pubmed: 35592392
Medicina (Kaunas). 2021 Jun 08;57(6):
pubmed: 34201104
Circulation. 2017 Sep 19;136(12):1155-1166
pubmed: 28923905
Curr Med Chem. 2011;18(21):3226-33
pubmed: 21671854
Clin Chim Acta. 2008 Jul 17;393(2):103-9
pubmed: 18423399
Clin Cancer Res. 2014 Dec 1;20(23):6212-22
pubmed: 25271081
JAMA Cardiol. 2016 Sep 1;1(6):718-30
pubmed: 27438381
J Exp Med. 2002 Oct 7;196(7):887-96
pubmed: 12370251
J Am Coll Cardiol. 2007 Nov 27;50(22):2117-24
pubmed: 18036447
J Clin Med. 2021 Sep 14;10(18):
pubmed: 34575256
Acta Cardiol Sin. 2016 Nov;32(6):676-683
pubmed: 27899854
BMC Neurol. 2013 Jan 15;13:7
pubmed: 23317415
J Am Coll Cardiol. 2009 Dec 1;54(23):2129-38
pubmed: 19942084
BMC Public Health. 2018 Nov 6;18(1):1232
pubmed: 30400967
Circulation. 2018 Jul 10;138(2):141-149
pubmed: 29716940
J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):170-8
pubmed: 24177335
Semin Thromb Hemost. 2016 Apr;42(3):223-33
pubmed: 26926585
Biomark Med. 2020 Nov;14(16):1553-1561
pubmed: 33179524
J Intern Med. 2012 Sep;272(3):298-304
pubmed: 22303818
J Clin Invest. 2005 Dec;115(12):3378-84
pubmed: 16322783
Eur Heart J. 2004 Aug;25(15):1287-92
pubmed: 15288155
Obes Facts. 2015;8(6):402-24
pubmed: 26641646
Acta Med Iran. 2010 Jan-Feb;48(1):51-7
pubmed: 21137670
Coron Artery Dis. 2010 Jan;21(1):1-7
pubmed: 20050312
Eur Heart J. 2020 Feb 1;41(6):748-758
pubmed: 31317172
J Clin Med. 2019 Oct 27;8(11):
pubmed: 31717832
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
J Immunol Res. 2020 Aug 18;2020:4904217
pubmed: 32908939
Front Cardiovasc Med. 2022 Feb 17;9:811079
pubmed: 35252391
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Curr Atheroscler Rep. 2017 Mar;19(3):11
pubmed: 28194569
Eur J Med Res. 2022 Jul 2;27(1):106
pubmed: 35780134
Front Oncol. 2020 May 13;10:766
pubmed: 32477958
Platelets. 2015;26(7):680-1
pubmed: 25549287
Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31
pubmed: 22238190
Cell. 2022 May 12;185(10):1630-1645
pubmed: 35504280
Nat Rev Cardiol. 2019 Aug;16(8):455
pubmed: 31101895
Am J Cardiol. 1997 Mar 15;79(6):812-4
pubmed: 9070569
Circ Res. 2019 Jan 4;124(1):150-160
pubmed: 30605419
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129
pubmed: 34895950
BMJ Open. 2019 Oct 30;9(10):e030949
pubmed: 31666267
Eur Heart J. 2011 Jan;32(1):84-92
pubmed: 20943670
Perfusion. 2022 Sep;37(6):605-612
pubmed: 33960235
Ann Intern Med. 2009 Oct 6;151(7):483-95
pubmed: 19805771
Angiology. 2021 Jul;72(6):575-581
pubmed: 33685239
J Am Coll Cardiol. 2005 May 17;45(10):1638-43
pubmed: 15893180
Ann Med. 2022 Dec;54(1):1667-1677
pubmed: 35695557
J Am Coll Cardiol. 2017 Mar 7;69(9):1160-1169
pubmed: 28254179
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Int Immunopharmacol. 2018 Dec;65:503-510
pubmed: 30408627
Eur J Clin Invest. 2020 May;50(5):e13230
pubmed: 32291748
J Hypertens. 2021 Jul 1;39(7):1293-1302
pubmed: 33710173
Biofactors. 2012 Sep-Oct;38(5):320-8
pubmed: 22628054
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
BMC Cardiovasc Disord. 2022 Feb 13;22(1):45
pubmed: 35152878
PLoS One. 2017 Jul 28;12(7):e0180332
pubmed: 28753607
J Transl Med. 2018 Oct 4;16(1):273
pubmed: 30286769
Immunobiology. 2012 May;217(5):476-82
pubmed: 22325375
N Engl J Med. 2012 Oct 4;367(14):1310-20
pubmed: 23034020

Auteurs

Ewelina A Dziedzic (EA)

Medical Faculty, Lazarski University in Warsaw, 02-662 Warsaw, Poland.
Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

Jakub S Gąsior (JS)

Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland.

Agnieszka Tuzimek (A)

Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

Justyna Paleczny (J)

Department of Pharmaceutical Microbiology and Parasitology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Adam Junka (A)

Department of Pharmaceutical Microbiology and Parasitology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Marek Dąbrowski (M)

Department of Cardiology, Bielanski Hospital, 01-809 Warsaw, Poland.

Piotr Jankowski (P)

Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
Department of Epidemiology and Health Promotion, School of Public Health, Center of Postgraduate Medical Education, 01-826 Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH